Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 149.78 Million CNY | 1105.95% |
| 2022 | 12.42 Million CNY | -33.31% |
| 2021 | 18.62 Million CNY | -23.88% |
| 2020 | 24.46 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 204.68 Million CNY | 1.37% |
| 2024 Q1 | 176.18 Million CNY | 17.62% |
| 2024 Q2 | 198.33 Million CNY | 12.58% |
| 2023 Q2 | 117.25 Million CNY | 30.05% |
| 2023 FY | 149.78 Million CNY | 1105.95% |
| 2023 Q3 | 141.01 Million CNY | 20.26% |
| 2023 Q4 | 149.78 Million CNY | 6.22% |
| 2023 Q1 | 90.16 Million CNY | 625.93% |
| 2022 Q3 | 13.73 Million CNY | -7.9% |
| 2022 Q1 | 16.78 Million CNY | -9.9% |
| 2022 FY | 12.42 Million CNY | -33.31% |
| 2022 Q4 | 12.42 Million CNY | -9.59% |
| 2022 Q2 | 14.91 Million CNY | -11.11% |
| 2021 Q2 | 34.67 Million CNY | 24.39% |
| 2021 FY | 18.62 Million CNY | -23.88% |
| 2021 Q4 | 18.62 Million CNY | -8.91% |
| 2021 Q3 | 20.44 Million CNY | -41.04% |
| 2021 Q1 | 27.87 Million CNY | 13.93% |
| 2020 Q3 | 16.98 Million CNY | 0.0% |
| 2020 Q4 | 24.46 Million CNY | 44.01% |
| 2020 FY | 24.46 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |